4.8 Article

Unfermented b-fructan Fibers Fuel Inflammation in Select Inflammatory Bowel Disease Patients

Journal

GASTROENTEROLOGY
Volume 164, Issue 2, Pages 228-240

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.gastro.2022.09.034

Keywords

Dietary Fibers; Microbiome; IBD; Fermentation

Ask authors/readers for more resources

Dietary fibers play a role in inflammatory bowel diseases (IBD) by fermenting in the colon, but not all fibers are beneficial. Some IBD patients are intolerant to fiber consumption. This study found that intact b-fructan fibers in certain IBD patients without fermentative microbes can induce gut inflammation by binding to host cell receptors.
BACKGROUND & AIMS: Inflammatory bowel diseases (IBD) are affected by dietary factors, including nondigestible carbohydrates (fibers), which are fermented by colonic microbes. Fibers are overall beneficial, but not all fibers are alike, and some patients with IBD report intolerance to fiber consumption. Given repro-ducible evidence of reduced fiber-fermenting microbes in patients with IBD, we hypothesized that fibers remain intact in select pa-tients with reduced fiber-fermenting microbes and can then bind host cell receptors, subsequently promoting gut inflammation. METHODS: Colonic biopsies cultured ex vivo and cell lines in vitro were incubated with oligofructose (5 g/L), or fermentation su-pernatants (24-hour anaerobic fermentation) and immune re-sponses (cytokine secretion [enzyme-linked immunosorbent assay/meso scale discovery] and expression [quantitative poly-merase chain reaction]) were assessed. Influence of microbiota in mediating host response was examined and taxonomic classifi- cation of microbiota was conducted with Kraken2 and metabolic profiling by HUMAnN2, using R software. RESULTS: Unfermented dietary b-fructan fibers induced proinflammatory cytokines in a subset of IBD intestinal biopsies cultured ex vivo, and immune cells (including peripheral blood mononuclear cells). Results were validated in an adult IBD randomized controlled trial examining b- fructan supplementation. The proinflammatory response to intact b-fructan required activation of the NLRP3 and TLR2 pathways. Fermentation of b-fructans by human gut whole microbiota cul-tures reduced the proinflammatory response, but only when mi-crobes were collected from patients without IBD or patients with inactive IBD. Fiber-induced immune responses correlated with microbe functions, luminal metabolites, and dietary fiber avoidance. CONCLUSION: Although fibers are typically beneficial in individuals with normal microbial fermentative potential, some dietary fibers have detrimental effects in select patients with active IBD who lack fermentative microbe activities. The study is publicly accessible at the U.S. National Institutes of Health data-base (clinicaltrials.gov identification number NCT02865707).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Gastroenterology & Hepatology

Early Infliximab Clearance Predicts Remission in Children with Crohn's Disease

Aaron Chung, Matthew Carroll, Patricia Almeida, Alexandra Petrova, Daniela Isaac, Diane Mould, Eytan Wine, Hien Huynh

Summary: Early infliximab clearance is strongly associated with remission in children with Crohn's disease and may serve as a predictive marker for treatment outcomes.

DIGESTIVE DISEASES AND SCIENCES (2023)

Review Nutrition & Dietetics

The separate effects of whole oats and isolated beta-glucan on lipid profile: A systematic review and meta-analysis of randomized controlled trials*

Alcides C. de Morais Junior, Raquel M. Schincaglia, Ricardo B. Viana, Anissa M. Armet, Carla M. Prado, Jens Walter, Joao F. Mota

Summary: This study assessed the impact of oats or fi-glucan supplements on lipid profiles through a systematic review and meta-analysis. The results showed that both oats and fi-glucan improved lipid profiles, indicating their potential role in preventing cardiovascular diseases.

CLINICAL NUTRITION ESPEN (2023)

Article Biology

A phylogenomic analysis of Limosilactobacillus reuteri reveals ancient and stable evolutionary relationships with rodents and birds and zoonotic transmission to humans

Fuyong Li, Xudong Li, Christopher C. Cheng, Dalimil Bujdos, Stephanie Tollenaar, David J. Simpson, Guergana Tasseva, Maria Elisa Perez-Munoz, Steven Frese, Michael G. Ganzle, Jens Walter, Jinshui Zheng

Summary: This study investigates the evolutionary relationship between different strains of Limosilactobacillus reuteri and their vertebrate hosts. It finds that there is a stable and long-term relationship between certain strains of L. reuteri and rodents and birds, while their relationship with other host species is more dynamic and transient. These findings contribute to our understanding of the role of gut microbes in hosts and have implications for microbial-based therapeutics.

BMC BIOLOGY (2023)

Editorial Material Biochemistry & Molecular Biology

Fecal microbiota-based treatment for recurrent Clostridioides difficile infection

Jens Walter, Fergus Shanahan

Article Nutrition & Dietetics

Metabolic signature of 13C-labeled wheat bran consumption related to gut fermentation in humans: a pilot study

Laure Meiller, Valerie Sauvinet, Anne-Esther Breyton, Harimalala Ranaivo, Christelle Machon, Anne Mialon, Alexandra Meynier, Stephan C. Bischoff, Jens Walter, Audrey M. Neyrinck, Martine Laville, Nathalie M. Delzenne, Sophie Vinoy, Julie-Anne Nazare

Summary: This pilot study aimed to analyze the kinetics of C-13-labeled gut-derived metabolites from C-13-labeled wheat bran in breath, plasma, and stools. The study found differential fermentation profiles among subjects and identified distinct excretion patterns of gases in high-CH4 producers compared to low-CH4 producers. The study also revealed different kinetics of C-13-labelled short-chain fatty acids in plasma.

EUROPEAN JOURNAL OF NUTRITION (2023)

Article Chemistry, Applied

Diversity of fibers in common foods: Key to advancing dietary research

Reihane Khorasaniha, Hana Olof, Athalia Voisin, Keith Armstrong, Eytan Wine, Thava Vasanthan, Heather Armstrong

Summary: Dietary fibers are plant-derived carbohydrates that cannot be digested in the human gut. They are traditionally classified as soluble dietary fiber (SDF) and insoluble dietary fiber (IDF) based on their solubility in water. Dietary fibers have significant impacts on various diseases, but the functionality of different fiber subtypes has been largely overlooked in clinical research.

FOOD HYDROCOLLOIDS (2023)

Article Biochemistry & Molecular Biology

Novel Biomarkers for Inflammatory Bowel Disease and Colorectal Cancer: An Interplay between Metabolic Dysregulation and Excessive Inflammation

Mohamed Salla, Jimmy Guo, Harshad Joshi, Marilyn Gordon, Hitesh Dooky, Justine Lai, Samantha Capicio, Heather Armstrong, Rosica Valcheva, Jason R. B. Dyck, Aducio Thiesen, Eytan Wine, Levinus A. Dieleman, Shairaz Baksh

Summary: Persistent inflammation can lead to changes in gene expression, metabolism, and cell proliferation. Inflammatory bowel disease (IBD) and colorectal cancer (CRC) share similar signaling pathways and biomarkers. This study identifies specific biomarkers, including RASSF1A, RIPK2, AMPK alpha 1, and YAP kinase, that are associated with IBD and CRC. The expression and activation of these biomarkers can be analyzed non-invasively in blood and biopsy samples. Understanding and targeting the altered proliferative and metabolic states in the colon could lead to more effective therapies and remission for IBD and CRC patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Pediatrics

Transition Readiness in Youth with Inflammatory Bowel Disease

Alice Foster, Justin M. Chan, Eytan Wine, Wael El-Matary, Matthew W. Carroll, Karen I. Kroeker, Jennifer C. Debruyn, Cynthia H. Seow, Sally Lawrence, Kathy Evans, Cheryl Kluthe, Nastaran Sharifi, Christina Pears, Simone Nicol, Lily Olayinka, Nancy Fu, Hien Q. Huynh, Brian Bressler, Charles N. Bernstein, Kevan Jacobson

Summary: This study examined the readiness of adolescents and young adults with inflammatory bowel disease (IBD) to transition to adult care. The results showed that a large proportion of AYAs lacked the knowledge and skills necessary for transition to adult care. Therefore, assessment tools for transition readiness are essential to identify deficits in knowledge and behavior skills that can be addressed by the youth, caregivers, and multidisciplinary team.

JOURNAL OF PEDIATRICS (2023)

Review Gastroenterology & Hepatology

Use of fiber-containing enteral formula in pediatric clinical practice: an expert opinion review

Paolo Lionetti, Eytan Wine, Rinat Ran Ressler, Gerard J. Minor, Giles Major, Boutaina Zemrani, Frederic Gottrand, Claudio Romano

Summary: Children who require enteral nutrition often experience gastrointestinal symptoms. Fiber-containing enteral formulas can improve bowel function, promote healthy gut microbiota growth, and improve immune homeostasis. However, there is a lack of guidance in clinical practice.

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2023)

Article Microbiology

Mouse mammary tumor virus is implicated in severity of colitis and dysbiosis in the IL-10-/- mouse model of inflammatory bowel disease

Heather Armstrong, Mandana Rahbari, Heekuk Park, David Sharon, Aducio Thiesen, Naomi Hotte, Ning Sun, Hussain Syed, Hiatem Abofayed, Weiwei Wang, Karen Madsen, Eytan Wine, Andrew Mason

Summary: Genetically manipulated mice lacking IL-10 have increased MMTV expression, which may contribute to the development of colitis. Antiviral therapy targeting MMTV reduces colonic MMTV RNA and improves colitis symptoms in these mice.

MICROBIOME (2023)

Article Microbiology

Evidence for a Causal Role for Escherichia coli Strains Identified as Adherent-Invasive (AIEC) in Intestinal Inflammation

Hatem Kittana, Joao C. Gomes-Neto, Kari Heck, Anthony F. Juritsch, Jason Sughroue, Yibo Xian, Sara Mantz, Rafael Segura R. Munoz, Liz A. Cody, Robert J. Schmaltz, Christopher L. Anderson, Rodney A. Moxley, Jesse M. Hostetter, Samodha C. Fernando, Jennifer Clarke, Stephen D. Kachman, Clayton E. Cressler, Andrew K. Benson, Jens Walter, Amanda E. Ramer-Tait

Summary: Inflammatory bowel disease (IBD) is associated with an altered gut microbiota composition, including expansion of Proteobacteria. Adherent-invasive Escherichia coli (AIEC) strains are enriched in some IBD patients, and AIEC strains show enhanced pathogenicity compared to non-AIEC strains. AIEC strains cause more severe intestinal inflammation and intracellular survival/replication phenotypes positively correlate with disease. This knowledge can be therapeutically exploited to alleviate intestinal inflammation.

MSPHERE (2023)

Article Nutrition & Dietetics

Gut microbiota alterations induced by intensive chemotherapy in acute myeloid leukaemia patients are associated with gut barrier dysfunction and body weight loss

Sarah A. Potgens, Sophie Lecop, Violaine Havelange, Fuyong Li, Audrey M. Neyrinck, Nathalie Neveux, Johan Maertens, Jens Walter, Helene Schoemans, Nathalie M. Delzenne, Laure B. Bindels

Summary: In this study, the researchers investigated the changes in gut microbiota induced by intensive therapy in acute myeloid leukaemia (AML) patients. They found that the therapy temporarily impaired the gut barrier function and led to long-lasting alterations in the composition and metabolic activity of the gut microbiota, which were associated with weight loss.

CLINICAL NUTRITION (2023)

Article Gastroenterology & Hepatology

Outcomes Following Acute Severe Colitis at Initial Presentation: A Multi-centre, Prospective, Paediatric Cohort Study

Jasbir Dhaliwal, Dominique Tertigas, Nicholas Carman, Sally Lawrence, Jennifer C. Debruyn, Eytan Wine, Peter C. Church, Hien Q. Huynh, Mohsin Rashid, Wael El-Matary, Colette Deslandres, Jeffrey Critch, Amanda Ricciuto, Matthew W. Carroll, Eric Benchimol, Aleixo Muise, Kevan Jacobson, Anthony R. Otley, Bruce Vallance, David R. Mack, Thomas D. Walters, Michael G. Surette, Anne M. Griffiths

Summary: This study assessed contemporary outcomes in children with acute severe ulcerative colitis (ASUC) and found that the majority of children require escalation to biologic therapy. Predictors of the need for advanced therapy were identified.

JOURNAL OF CROHNS & COLITIS (2023)

No Data Available